Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration

Oncogene volume 34, pages 3711–3727 (2015)Cite this article

Subjects

Abstract

Glioblastoma is the most common and lethal primary malignant brain tumor in adults. The tumor suppressor gene PTEN is deleted, mutated or hypermethylated in more than 60% of glioblastoma cases resulting in hyperactivation of the phosphoinositide 3-kinase pathway, which leads to sustained PI(3,4,5)P3 signaling, and thereby hyperactivation of Akt and other effectors. PI(3,4,5)P3 is also hydrolyzed to PI(3,4)P2 by inositol polyphosphate 5-phosphatases such as SKIP, but the role this pathway has in glioblastoma is unknown. Microarray expression profiling of SKIP in human glioblastoma has revealed both increased and decreased SKIP gene expression. Here we have screened PTEN-deficient glioblastoma for SKIP protein expression by immunohistochemistry and report that SKIP expression is increased in some cases or decreased relative to normal brain. Using the U-87MG PTEN-deficient cell line we show that SKIP knockdown did not further enhance cell proliferation or survival. However, SKIP overexpression in U-87MG cells suppressed anchorage-independent cell growth and growth factor-induced PI(3,4,5)P3/Akt signaling. Although, SKIP knockdown did not affect cell proliferation or survival, cell migration was significantly retarded, associated with significantly increased PI(4,5)P2 signals, and decreased phosphorylation of the actin-regulatory protein cofilin, a PI(4,5)P2-binding protein. Notably, overexpression of SKIP also inhibited migration of U-87MG cells to a similar degree as observed with PTEN reconstitution, however, via distinct mechanisms. PTEN reconstitution promoted sustained lamellipodia generation and focal adhesion formation. In contrast, SKIP overexpression reduced sustained lamellipodia formation, talin incorporation into focal adhesions and recruitment of PI(4,5)P2-binding proteins to the plasma membrane. Notably, analysis of two independent ONCOMINE microarray data sets revealed a significant correlation between increased SKIP mRNA expression in glioblastoma and improved long-term survival. Therefore, SKIP expression in glioblastoma may affect the local invasion of PTEN-deficient tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  1. Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 2008; 10: 79–87.

    PubMed  PubMed Central  Google Scholar 

  2. Rao JS . Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003; 3: 489–501.

    CAS  PubMed  Google Scholar 

  3. Franke TF . PI3K/Akt: Getting it right matters. Oncogene 2008; 27: 6473–6488.

    CAS  PubMed  Google Scholar 

  4. Zhang L, Mao YS, Janmey PA, Yin HL . Phosphatidylinositol 4, 5 bisphosphate and the actin cytoskeleton. In: Balla T, Wymann M, York JD (eds) Phosphoinositides II: The Diverse Biological Functions. Springer: The Netherlands, 2012, pp 177–215.

    Google Scholar 

  5. Davies EM, Sheffield DA, Tibarewal P, Fedele CG, Mitchell CA, Leslie NR . The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease. Subcell Biochem 2012; 58: 281–336.

    CAS  PubMed  Google Scholar 

  6. Koul D . PTEN signaling pathways in glioblastoma. Cancer Biol Ther 2008; 7: 1321–1325.

    CAS  PubMed  Google Scholar 

  7. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 2007; 104: 20007–20012.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391–403.

    CAS  PubMed  Google Scholar 

  9. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999; 59: 1820–1824.

    CAS  PubMed  Google Scholar 

  10. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9: 287–300.

    CAS  PubMed  Google Scholar 

  11. Dyson JM, Fedele CG, Davies EM, Becanovic J, Mitchell CA . Phosphoinositide phosphatases: just as important as the kinases. Subcell Biochem 2012; 58: 215–279.

    CAS  PubMed  Google Scholar 

  12. Gurung R, Tan A, Ooms LM, McGrath MJ, Huysmans RD, Munday AD et al. Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization: the inositol 5-phosphatase SKIP localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation. J Biol Chem 2003; 278: 11376–11385.

    CAS  PubMed  Google Scholar 

  13. Ijuin T, Mochizuki Y, Fukami K, Funaki M, Asano T, Takenawa T . Identification and characterization of a novel inositol polyphosphate 5- phosphatase. J Biol Chem 2000; 275: 10870–10875.

    CAS  PubMed  Google Scholar 

  14. Ijuin T, Takenawa T . SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol Cell Biol 2003; 23: 1209–1220.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Ijuin T, Takenawa T . Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP). J Biol Chem 2012; 287: 6991–6999.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Ijuin T, Yu YE, Mizutani K, Pao A, Tateya S, Tamori Y et al. Increased insulin action in SKIP heterozygous knockout mice. Mol Cell Biol 2008; 28: 5184–5195.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Schmid AC, Wise HM, Mitchell CA, Nussbaum R, Woscholski R . Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett 2004; 576: 9–13.

    CAS  PubMed  Google Scholar 

  18. Biegel JA, Burk CD, Barr FG, Emanuel BS . Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 1992; 52: 3391–3395.

    CAS  PubMed  Google Scholar 

  19. Rood BR, Zhang H, Weitman DM, Cogen PH . Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 2002; 62: 3794–3797.

    CAS  PubMed  Google Scholar 

  20. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU . Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 1992; 52: 6716–6721.

    CAS  PubMed  Google Scholar 

  21. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD et al. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 2005; 65: 4088–4096.

    CAS  PubMed  Google Scholar 

  22. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 2005; 102: 5814–5819.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF et al. Stem cell-related ‘self-renewal’ signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008; 26: 3015–3024.

    CAS  PubMed  Google Scholar 

  24. Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, Tanaka R et al. Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 2006; 25: 5994–6002.

    CAS  PubMed  Google Scholar 

  25. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003; 63: 1602–1607.

    CAS  PubMed  Google Scholar 

  26. Chalhoub N, Zhu G, Zhu X, Baker SJ . Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev 2009; 23: 1619–1624.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Baeza N, Weller M, Yonekawa Y, Kleihues P, Ohgaki H . PTEN methylation and expression in glioblastomas. Acta Neuropathol 2003; 106: 479–485.

    CAS  PubMed  Google Scholar 

  28. Carico C, Nuño M, Mukherjee D, Elramsisy A, Dantis J, Hu J et al. Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. PLoS ONE 2012; 7: e33684.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Furnari FB, Lin H, Huang HJS, Cavenee WK . Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94: 12479–12484.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356–362.

    Article  CAS  PubMed  Google Scholar 

  31. Kaplan PL, Anderson M, Ozanne B . Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system. Proc Natl Acad Sci USA 1982; 79: 485–489.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS . Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 1997; 17: 4406–4418.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Van Oers MHJ . Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415–1420.

    CAS  PubMed  Google Scholar 

  34. Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57–70.

    CAS  PubMed  Google Scholar 

  35. Klingler-Hoffmann M, Bukczynska P, Tiganis T . Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells. Int J Cancer 2003; 105: 331–339.

    CAS  PubMed  Google Scholar 

  36. Li DM, Sun H . PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 1998; 95: 15406–15411.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Frisch SM, Francis H . Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619–626.

    CAS  PubMed  Google Scholar 

  38. Guadamillas MC, Cerezo A, del Pozo MA . Overcoming anoikis—pathways to anchorageindependent growth in cancer. J Cell Sci 2011; 124: 3189–3197.

    CAS  PubMed  Google Scholar 

  39. Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 1998; 58: 5285–5290.

    CAS  PubMed  Google Scholar 

  40. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK et al. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 2001; 20: 6669–6678.

    CAS  PubMed  Google Scholar 

  41. Tamura M, Gu J, Danen EHJ, Takino T, Miyamoto S, Yamada KM . PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1999; 274: 20693–20703.

    CAS  PubMed  Google Scholar 

  42. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE . Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 2004; 135: 555–562.

    CAS  PubMed  Google Scholar 

  43. Folkman J, Moscona A . Role of cell shape in growth control. Nature 1978; 273: 345–349.

    CAS  PubMed  Google Scholar 

  44. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

    CAS  PubMed  Google Scholar 

  45. Hinchliffe KA, Irvine RF, Divecha N . Aggregation-dependent, integrin-mediated increases in cytoskeletally associated PtdInsP2 (4,5) levels in human platelets are controlled by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton. EMBO J 1996; 15: 6516–6524.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Guo W, Giancotti FG . Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816–826.

    CAS  PubMed  Google Scholar 

  47. Gu J, Tamura M, Pankov R, Danen EHJ, Takino T, Matsumoto K et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999; 146: 389–403.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Tamura M, Gu J, Takino T, Yamada KM . Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130(Cas). Cancer Res 1999; 59: 442–449.

    CAS  PubMed  Google Scholar 

  49. Iijima M, Devreotes P . Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 2002; 109: 599–610.

    CAS  PubMed  Google Scholar 

  50. Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y et al. Regulation of PTEN by Rho small GTPases. Nat Cell Biol 2005; 7: 399–404.

    CAS  PubMed  Google Scholar 

  51. Cain RJ, Ridley AJ . Phosphoinositide 3-kinases in cell migration. Biol Cell 2009; 101: 13–29.

    CAS  PubMed  Google Scholar 

  52. Frame M, Norman J . A tal(in) of cell spreading. Nat Cell Biol 2008; 10: 1017–1019.

    CAS  PubMed  Google Scholar 

  53. Mise-Omata S, Obata Y, Iwase S, Mise N, Doi TS . Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells. Biochem Biophys Res Commun 2005; 328: 1034–1042.

    CAS  PubMed  Google Scholar 

  54. Várnai P, Bondeva T, Tamás P, Tóth B, Buday L, Hunyady L et al. Selective cellular effects of overexpressed pleckstrin-homology domains that recognize Ptdlns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci 2005; 118: 4879–4888.

    PubMed  Google Scholar 

  55. Várnai P, Balla T . Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol 1998; 143: 501–510.

    PubMed  PubMed Central  Google Scholar 

  56. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, Ampe C . Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol 2008; 87: 649–667.

    CAS  PubMed  Google Scholar 

  57. Gorbatyuk VY, Nosworthy NJ, Robson SA, Bains NPS, Maciejewski MW, dos Remedios CG et al. Mapping the phosphoinositide-binding site on chick cofilin explains how PIP2 regulates the cofilin-actin interaction. Mol Cell 2006; 24: 511–522.

    CAS  PubMed  Google Scholar 

  58. Zhao H, Hakala M, Lappalainen P . ADF/cofilin binds phosphoinositides in a multivalent manner to act as a PIP(2)-density sensor. Biophys J 2010; 98: 2327–2336.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Arber S, Barbayannis FA, Hanser H, Schnelder C, Stanyon CA, Bernards O et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM- kinase. Nature 1998; 393: 805–809.

    CAS  PubMed  Google Scholar 

  60. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K et al. Cofflin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998; 393: 809–812.

    CAS  PubMed  Google Scholar 

  61. Huang S, Lifshitz L, Patki-Kamath V, Tuft R, Fogarty K, Czech MP . Phosphatidylinositol-4,5-bisphosphate-rich plasma membrane patches organize active zones of endocytosis and ruffling in cultured adipocytes. Mol Cell Biol 2004; 24: 9102–9123.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Kisseleva M, Feng Y, Ward M, Song C, Anderson RA, Longmore GD . The LIM protein Ajuba regulates phosphatidylinositol 4,5-bisphosphate levels in migrating cells through an interaction with and activation of PIPKIα. Mol Cell Biol 2005; 25: 3956–3966.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Sasaki J, Sasaki T, Yamazaki M, Matsuoka K, Taya C, Shitara H et al. Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I α. J Exp Med 2005; 201: 859–870.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Shibasaki Y, Ishihara H, Kizuki N, Asano T, Oka Y, Yazaki Y . Massive actin polymerization induced by phosphatidylinositol-4-phosphate 5-kinase in vivo. J Biol Chem 1997; 272: 7578–7581.

    CAS  PubMed  Google Scholar 

  65. Watt SA, Kular G, Fleming IN, Downes CP, Lucocq JM . Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C δ1. Biochem J 2002; 363: 657–666.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Di Paolo G, De Camilli P . Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443: 651–657.

    CAS  PubMed  Google Scholar 

  67. Calderwood DA, Ginsberg MH . Talin forges the links between integrins and actin. Nat Cell Biol 2003; 5: 694–697.

    CAS  PubMed  Google Scholar 

  68. Hynes RO . Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673–687.

    CAS  PubMed  Google Scholar 

  69. Martel V, Racaud-Sultan C, Dupe S, Marie C, Paulhe F, Galmiche A et al. Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem 2001; 276: 21217–21227.

    CAS  PubMed  Google Scholar 

  70. Takenawa T, Itoh T . Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim Biophys Acta 2001; 1533: 190–206.

    CAS  PubMed  Google Scholar 

  71. Yin HL, Janmey PA . Phosphoinositide regulation of the actin cytoskeleton. Ann Rev Physiol 2003, pp 761–789.

    CAS  PubMed  Google Scholar 

  72. Leslie NR, Yang X, Downes CP, Weijer CJ . PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 2007; 17: 115–125.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Liliental J, Moon SY, Lesche R, Mamillapalli R, Li D, Zheng Y et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 2000; 10: 401–404.

    CAS  PubMed  Google Scholar 

  74. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A . Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004; 303: 1179–1181.

    CAS  PubMed  Google Scholar 

  75. Di Paolo G, Pellegrini L, Letinic K, Cestra G, Zoncu R, Voronov S et al. Recruitment and regulation of phosphatidylinositol phosphate kinase type 1γ by the FERM domain of talin. Nature 2002; 420: 85–89.

    CAS  PubMed  Google Scholar 

  76. Ling K, Doughman RL, Firestone AJ, Bunce MW, Anderson RA . Type Iγ phosphatidylinositol phosphate kinase targets and regulates focal adhesions. Nature 2002; 420: 89–93.

    CAS  PubMed  Google Scholar 

  77. Bertagnolo V, Benedusi M, Brugnoli F, Lanuti P, Marchisio M, Querzoli P et al. Phospholipase C-β2 promotes mitosis and migration of human breast cancer-derived cells. Carcinogenesis 2007; 28: 1638–1645.

    CAS  PubMed  Google Scholar 

  78. Golub T, Caroni P . PI(4/5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motility. J Cell Biol 2005; 169: 151–165.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Campbell RB, Liu F, Ross AH . Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2003; 278: 33617–33620.

    CAS  PubMed  Google Scholar 

  80. Iijima M, Huang YE, Luo HR, Vazquez F, Devreotes PN . Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J Biol Chem 2004; 279: 16606–16613.

    CAS  PubMed  Google Scholar 

  81. Pfaffl MW . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2003–2007.

    Google Scholar 

  82. Abràmoff MD, Magalhães PJ, Ram SJ . Image processing with imageJ. Biophoton Int 2004; 11: 36–41.

    Google Scholar 

  83. Ooms LM, Fedele CG, Astle MV, Ivetac I, Cheung V, Pearson RB et al. The inositol polyphosphate 5-phosphatase, PIPP, is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol Biol Cell 2006; 17: 607–622.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Hammond GRV, Schiavo G, Irvine RF . Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P2. Biochem J 2009; 422: 23–35.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Tamas Balla (NIH) for kindly providing the GFP-PH/Btk and GFP-PH/PLCδ constructs and Dr Jelena Becanovic for assistance with ONCOMINE data analysis. This work was supported by the National Health & Medical Research Council (NH&MRC), Australia, grant number 384083. We also thank the Biochemistry Imaging Facility, Department of Biochemistry and Molecular Biology, Monash University and the Monash Micro Imaging Facility for technical advice with image acquisition and analysis. Tony Tiganis is a NHMRC research fellow. The results shown here are in part based upon data generated by The Cancer Genome Atlas Research Network http://cancergenome.nih.gov/.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia

    E M Davies, A M Kong, A Tan, R Gurung, A Sriratana, P E Bukczynska, L M Ooms, T Tiganis & C A Mitchell

  2. Department of Anatomical Pathology, Alfred Hospital, Prahran, Victoria, Australia

    C A McLean

Authors
  1. E M Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A M Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Gurung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Sriratana
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P E Bukczynska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L M Ooms
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C A McLean
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Tiganis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C A Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C A Mitchell.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davies, E., Kong, A., Tan, A. et al. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration. Oncogene 34, 3711–3727 (2015). https://doi.org/10.1038/onc.2014.303

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2014.303

This article is cited by

Search

Advanced search

Quick links